UMB Financial Corp: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Oct 29, 2020 and accepted by EDGAR at Oct 29, 2020, 09:02 ET.
Management's discussion and analysis
As filed, 72,629 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations highlights the material changes in the results of operations and changes in financial condition of the Company for the three and nine-month periods ended September 30, 2020. It should be read in conjunction with the accompanying Consolidated Financial Statements, Notes to Consolidated Financial Statements and other financial information appearing elsewhere in this Form 10-Q and the Form 10-K. Results of operations for the periods included in this review are not necessarily indicative of results to be attained during any future period.
CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS
From time to time the Company has made, and in the future will make, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “outlook,” “forecast,” “target,” “trend,” “plan,” “goal,” or other words of comparable meaning or future-tense or conditional verbs such as “may,” “will,” “should,” “would,” or “could.” Forward-looking statements convey the Company’s expectations, intentions, or forecasts about future events, circumstances, results, or aspirations, in each case as of the date such forward-looking statements are made.
This Form 10-Q, including any information incorporated by reference in this Form 10-Q, contains forward-looking statements. The Company also may make forward-looking statements in other documents that are filed or furnished with the Securities and Exchange Commission. In addition, the Company may make forward-looking statements orally or in writing to investors, analysts, members of the media, or others.
All forward-looking statements, by their nature, are subject to assumptions, risks, and uncertainties, which may change over time and many of which are beyond the Company’s control. You should not rely on any forward-looking statement as a prediction or guarantee about the future. Actual future objectives, strategies, plans, prospects, performance, conditions, or results may differ materially from those set forth in any forward-looking statement. While no list of assumptions, risks, or uncertainties could be complete, some of the factors that may cause actual results or other future events, circumstances, or aspirations to differ from those in forward-looking statements include:
- local, regional, national, or international business, economic, or political conditions or events;
- changes in laws or the regulatory environment, including as a result of financial-services legislation or regulation;
- changes in monetary, fiscal, or trade laws or policies, including as a result of actions by central banks or supranational authorities;
- changes in accounting standards or policies;
- shifts in investor sentiment or behavior in the securities, capital, or other financial markets, including changes in market liquidity or volatility or changes in interest or currency rates;
- changes in spending, borrowing, or saving by businesses or households;
- the Company’s ability to effectively manage capital or liquidity or to effectively attract or deploy deposits;
- changes in any credit rating assigned to the Company or its affiliates;
- adverse publicity or other reputational harm to the Company;
- changes in the Company’s corporate strategies, the composition of its assets, or the way in which it funds those assets;
- the Company’s ability to develop, maintain, or market products or services or to absorb unanticipated costs or liabilities associated with those products or services;
- the Company’s ability to innovate to anticipate the needs of current or future customers, to successfully compete in its chosen business lines, to increase or hold market share in changing competitive environments, or to deal with pricing or other competitive pressures;
- changes in the credit, liquidity, or other condition of the Company’s customers, counterparties, or competitors;
- the Company’s ability to effectively deal with economic, business, or market slowdowns or disruptions;
- judicial, regulatory, or administrative investigations, proceedings, disputes, or rulings that create uncertainty for, or are adverse to, the Company or the financial-services industry;
- the Company’s ability to address changing or stricter regulatory or other governmental supervision or requirements;
- the Company’s ability to maintain secure and functional financial, accounting, technology, data processing, or other operating systems or facilities, including its capacity to withstand cyber-attacks;
- the adequacy of the Company’s corporate governance, risk-management framework, compliance programs, or internal controls, including its ability to control lapses or deficiencies in financial reporting or to effectively mitigate or manage operational risk;
- the efficacy of the Company’s methods or models in assessing business strategies or opportunities or in valuing, measuring, monitoring, or managing positions or risk;
- the Company’s ability to keep pace with changes in technology that affect the Company or its customers, counterparties, or competitors;
- mergers, acquisitions, or dispositions, including the Company’s ability to integrate acquisitions and divest assets;
- the adequacy of the Company’s succession planning for key executives or other personnel;
- the Company’s ability to grow revenue, control expenses, or attract and retain qualified employees;
- natural disasters, war, terrorist activities, pandemics, or the outbreak of COVID-19 or similar outbreaks, and their effects on economic and business environments in which the Company operates;
- adverse effects due to COVID-19 on the Company and its customers, counterparties, employees, and third-party service providers, and the adverse impacts to our business, financial position, results of operations, and prospects; or
- other assumptions, risks, or uncertainties described in the Notes to Consolidated Financial Statements (Item 1) and Management’s Discussion and Analysis of Financial Condition and Results of Operations (Item 2) in this Form 10-Q, in the Risk Factors (Item 1A) in the Form 10-K, or in any of the Company’s quarterly or current reports.
Any forward-looking statement made by the Company or on its behalf speaks only as of the date that it was made. The Company does not undertake to update any forward-looking statement to reflect the impact of events, circumstances, or results that arise after the date that the statement was made, except as required by applicable securities laws. You, however, should consult further disclosures (including disclosures of a forward-looking nature) that the Company may make in any subsequent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, or Current Report on Form 8-K.
Overview
During the first quarter of 2020, the global economy began experiencing a downturn related to the impacts of the COVID-19 global pandemic (the COVID-19 pandemic, or the pandemic). Such impacts have included significant volatility in the global stock and fixed income markets, a 150-basis-point reduction in the target federal funds rate, the enactment of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, including the
Paycheck Protection Program (PPP) administered by the Small Business Administration, and a variety of rulings from the Company’s banking regulators.
The Company continues to actively monitor developments related to COVID-19 and its impact to its business, customers, employees, counterparties, vendors, and service providers. During the third quarter of 2020, the Company’s results of operations included continued building of the allowance for credit losses and monitoring key macroeconomic variables utilized in the econometric models under the CECL accounting standard adopted on January 1, 2020 and $1.4 million of nonrecurring COVID-19 specific expenses. Additionally, the Company continued to see impacts of the volatile equity and debt markets and low interest rate environment in its fee-based businesses.
In response to the COVID-19 pandemic, the Company formed a Pandemic Taskforce and a steering group comprised of associates across multiple lines of business and support functions and has taken several actions to offer various forms of support to our customers, employees, and communities that have experienced impacts resulting from the COVID-19 pandemic. Approximately 65% of the Company’s associates are working remotely. The Company has also increased purchases of computer hardware to support a remote workforce, as well as incurred additional cleaning and janitorial expense to disinfect branch and office locations. The Company is also actively working with customers impacted by the economic downturn by offering payment deferrals and other loan modifications. See further details under “Credit Risk Management” within “Item 3. Quantitative and Qualitative Disclosures about Market Risk.” Additionally, the Company has recorded over 5,000 loans totaling $1.5 billion under the PPP.
In light of volatility in the capital markets and economic disruptions, the Company continues to carefully monitor its capital and liquidity position. In March 2020, the U.S. banking agencies issued an interim final rule that provides banking organizations with an alternative option to delay for two years an estimate of CECL's effect on regulatory capital, relative to the incurred loss methodology’s effect on regulatory capital, followed by a three-year transition period. The Company elected this alternative in the first quarter of 2020. The Company continues to anticipate that it will have sufficient capital levels to meet all applicable regulatory capital requirements.
The COVID-19 pandemic and stay-at-home and similar mandates have also necessitated certain actions related to the way the Company operates its business. As noted above, the Company transitioned most of its workforce off-site or to work-from-home to help mitigate health risks. The Company is also carefully monitoring the activities of its vendors and other third-party service providers to mitigate the risks associated with any potential service disruptions. The length of time it may be required to operate under such circumstances and future degrees of disruption remain uncertain. While the Company has not experienced material adverse disruptions to its internal operations due to the pandemic, it continues to review evolving risks and developments.
The Company has detailed the impact of the COVID-19 pandemic in each applicable section of “Management's Discussion and Analysis of Financial Condition and Results of Operations” included below.
The Company focuses on the following strategic objectives to guide its efforts to achieve its vision, to deliver the unparalleled customer experience, all while seeking to improve net income and strengthen the balance sheet while undertaking prudent risk management.
The first strategic objective is to continuously improve operating efficiencies. The Company has focused on identifying efficiencies that simplify our organizational and reporting structures, streamline back office functions and take advantage of synergies and newer technologies among various platforms and distribution networks. The Company has identified and expects to continue identifying ongoing efficiencies through the normal course of business that, when combined with increased revenue, will contribute to improved operating leverage. During the third quarter of 2020, total revenue increased $25.5 million, or 9.4%, as compared to the third quarter of 2019, while noninterest expense increased $6.6 million, or 3.4%, for the same period. Included in the noninterest expense increase is $2.9 million of severance and $1.4 million of nonrecurring COVID-19 related expenses. The remaining increase in noninterest expense is primarily driven by an increase in bonus and commission expense, deferred compensation expense, and salary and wage expense, partially offset by a decrease in marketing and business development expense, consulting expense, and operational losses. As part of the initiative to improve operating efficiencies, the Company continues to invest in technological advances that it believes will help management drive operating leverage in the future through improved data analysis and automation. The Company also continues to evaluate core systems and will invest in enhancements that it believes will yield operating efficiencies.
The second strategic objective is to increase net interest income through profitable loan and deposit growth and the optimization of the balance sheet. During the third quarter of 2020, the Company had an increase in net interest income of $16.1 million, or 9.6%, from the same period in 2019. The Company has shown increased net interest income through the effects of increased volume and mix of average earning assets. Loans recorded under the PPP increased loan interest income by $8.7 million in the third quarter of 2020. The additional increase in interest income was driven by an increase of $1.3 billion in non-PPP loans. These increases were offset by the recent interest rate reductions. Average loan balances increased $2.8 billion, or 22.0%, for the third quarter of 2020, compared to the same period in 2019. Average PPP loans account for $1.5 billion of this variance. The funding for these assets was driven primarily by a 19.8% increase in average interest-bearing liabilities. Net interest margin, on a tax-equivalent basis, decreased 36 basis points compared to the same period in 2019, in large part due to a decrease in one-month LIBOR rates, excess liquidity buildup, and repricing of earning assets in the low interest rate environment, offset by a 100-basis point decrease in cost of interest-bearing deposits. However, net interest spread contracted by only one basis point during the same period. The Company expects to see continued volatility in the economic markets and government responses to the COVID-19 pandemic. These changing conditions and governmental responses could have impacts on the balance sheet and income statement of the Company for the remainder of the year.
The third strategic objective is to grow the Company’s revenue from noninterest sources. The Company seeks to grow noninterest revenues throughout all economic and interest rate cycles, while positioning itself to benefit in periods of economic growth. Noninterest income increased $9.4 million, or 9.0%, to $113.0 million for the three months ended September 30, 2020, compared to the same period in 2019. This change is primarily due to an increase in trust and securities processing, the market value of company-owned life insurance, derivative income, and trading and investment banking income. See greater detail below under Noninterest Income. The Company continues to emphasize its asset management, brokerage, bankcard services, healthcare services, and treasury management businesses. At September 30, 2020, noninterest income represented 38.0% of total revenues, compared to 38.1% at September 30, 2019. The recent economic changes have impacted fee income, especially those with assets tied to market values and interest rates.
The fourth strategic objective is effective capital management. The Company places a significant emphasis on maintaining a strong capital position, which management believes promotes investor confidence, provides access to funding sources under favorable terms, and enhances the Company’s ability to capitalize on business growth and acquisition opportunities. The Company continues to maximize shareholder value through a mix of reinvesting in organic growth, evaluating acquisition opportunities that complement the Company’s strategies, increasing dividends over time, and appropriately utilizing a share repurchase program. At September 30, 2020, the Company had $2.9 billion in total shareholders’ equity. This is an increase of $290.3 million, or 11.3%, compared to total shareholders’ equity at September 30, 2019. At September 30, 2020, the Company had a total risk-based capital ratio of 14.17%. The Company repurchased 2,262 shares of common stock at an average price of $46.91 per share during the third quarter of 2020. Total risk-based capital was favorably impacted by the $200 million subordinated note issuance during the third quarter. For additional information regarding the subordinated note issuance, please see the summary discussion in the “Deposits and Borrowed Funds” section included below.
Earnings Summary
The following is a summary regarding the Company’s earnings for the third quarter of 2020. The changes identified in the summary are explained in greater detail below. The Company recorded net income of $73.1 million for the three-month period ended September 30, 2020, compared to net income of $62.4 million for the same period a year earlier. This represents a 17.2% increase over the three-month period ended September 30, 2019. Basic earnings per share for the third quarter of 2020 was $1.52 per share ($1.52 per share fully-diluted) compared to $1.28 per share ($1.27 per share fully-diluted) for the third quarter of 2019. Return on average assets and return on average common shareholders’ equity for the three-month period ended September 30, 2020 were 0.99% and 10.23%, respectively, compared to 1.03% and 9.69%, respectively, for the three-month period ended September 30, 2019.
Net interest income for the three and nine-month periods ended September 30, 2020 increased $16.1 million, or 9.6%, and $38.0 million, or 7.6%, respectively, compared to the same periods in 2019. For the three-month period ended September 30, 2020, average earning assets increased by $5.5 billion, or 24.4%, and for the nine-month period ended September 30, 2020, they increased by $4.5 billion, or 20.5%, compared to the same periods in 2019. Net interest margin, on a tax-equivalent basis, decreased to 2.73% and 2.82% for the three and nine-month periods ended September 30, 2020, respectively, compared to 3.09% and 3.16%, for the same periods in 2019, respectively.
The provision for credit losses increased by $8.5 million to $16.0 million for the three-month period ended September 30, 2020 and increased by $94.7 million to $125.5 million for the nine-month period ended September 30, 2020, as compared to the same periods in 2019. This increase is the result of the adoption of the CECL standard in the first quarter of 2020 and applying this methodology for computing the allowance for credit losses, coupled with the impacts of the current and forecasted economic downturn related to the COVID-19 pandemic. The Company’s nonperforming loans increased $21.9 million to $93.7 million at September 30, 2020, compared to September 30, 2019. The allowance for credit losses on loans as a percentage of total loans increased to 1.33% as of September 30, 2020, compared to 0.82% at September 30, 2019. For a description of the Company’s methodology for computing the allowance for credit losses, please see the summary discussion in the “Provision and Allowance for Credit Losses” section included below.
Noninterest income increased by $9.4 million, or 9.0%, for the three-month period ended September 30, 2020, and increased by $15.5 million, or 4.9%, for the nine-month period ended September 30, 2020, compared to the same periods in 2019. These changes are discussed in greater detail below under Noninterest Income.
Noninterest expense increased by $6.6 million, or 3.4%, for the three-month period ended September 30, 2020, and increased by $19.7 million, or 3.4%, for the nine-month period ended September 30, 2020, compared to the same periods in 2019. These changes are discussed in greater detail below under Noninterest Expense.
Net Interest Income
Net interest income is a significant source of the Company’s earnings and represents the amount by which interest income on earning assets exceeds the interest expense paid on liabilities. The volume of interest-earning assets and the related funding sources, the overall mix of these assets and liabilities, and the rates paid on each affect net interest income. Net interest income for the three and nine-month periods ended September 30, 2020 increased $16.1 million, or 9.6%, and $38.0 million, or 7.6%, respectively, compared to the same periods in 2019.
Table 1 shows the impact of earning asset rate changes compared to changes in the cost of interest-bearing liabilities. As illustrated in this table, net interest spread for the three months ended September 30, 2020 decreased one basis point as compared to the same period in 2019. Net interest margin for the three months ended September 30, 2020 decreased 36 basis points compared to the same period in 2019. Net interest spread for the nine-month period ended September 30, 2020 decreased six basis points as compared to the same period in 2019. Net interest margin for the nine-month period ended September 30, 2020 decreased 34 basis points compared to the same period in 2019. The changes are primarily due to favorable volume variance on loans and securities and favorable rate variances on interest-bearing deposits, offset by unfavorable rate variances on earning assets. PPP loans account for $1.5 billion and $902.3 million for the three and nine-month periods ended September 30, 2020, respectively. These variances have led to an increase in the Company’s net interest income during 2020, as compared to results for the same period in 2019. The changes compared to last year have been impacted by the recent short-term interest rate cuts and increased liquidity on the balance sheet. The Company expects to see continued volatility in the economic markets and government responses to these changes as a result of the COVID-19 pandemic. These changing conditions and governmental responses could have impacts on the balance sheet and income statement of the Company the remainder of the year. For the impact of the contribution from free funds, see the Analysis of Net Interest Margin within Table 2 below. Table 2 also illustrates how the changes in volume and interest rates have resulted in an increase in net interest income.
AVERAGE BALANCE SHEETS/YIELDS AND RATES (tax-equivalent basis) (unaudited, dollars in thousands)
The following table presents, for the periods indicated, the average earning assets and resulting yields, as well as the average interest-bearing liabilities and resulting yields, expressed in both dollars and rates. All average balances are daily average balances. The average yield on earning assets without the tax-equivalent basis adjustment would have been 2.81% for the three-month period ended September 30, 2020, and 3.88% for the same period in 2019. The average yield on earning assets without the tax-equivalent basis adjustment would have been 3.05% for the nine-month period ended September 30, 2020 and 3.96% for the same period in 2019.
| ASSETS | Three Months Ended September 30, 2020 Average Balance | Average Yield/Rate | 2019 Average Balance | Average Yield/Rate |
|---|---|---|---|---|
| Loans, net of unearned interest | $15,731,716 | 3.60% | $12,890,878 | 4.99% |
| Securities: | ||||
| Taxable | 5,478,397 | 1.92 | 4,636,243 | 2.31 |
| Tax-exempt | 4,336,539 | 2.95 | 3,841,483 | 3.03 |
| Total securities | 9,814,936 | 2.37 | 8,477,726 | 2.63 |
| Federal funds and resell agreements | 1,177,590 | 0.76 | 394,587 | 2.83 |
| Interest-bearing due from banks | 1,087,838 | 0.11 | 582,116 | 2.35 |
| Other earning assets | 32,894 | 3.54 | 44,571 | 4.32 |
| Total earning assets | 27,844,974 | 2.91 | 22,389,878 | 3.99 |
| Allowance for credit losses | (211,221) | (104,795) | ||
| Other assets | 1,846,919 | 1,652,033 | ||
| Total assets | $29,480,672 | $23,937,116 | ||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
| Interest-bearing deposits | $15,867,017 | 0.23% | $13,226,432 | 1.23% |
| Federal funds and repurchase agreements | 1,964,161 | 0.35 | 1,683,072 | 1.96 |
| Borrowed funds | 115,943 | 5.56 | 69,927 | 7.86 |
| Total interest-bearing liabilities | 17,947,121 | 0.28 | 14,979,431 | 1.35 |
| Noninterest-bearing demand deposits | 8,260,170 | 6,082,498 | ||
| Other liabilities | 431,528 | 321,909 | ||
| Shareholders' equity | 2,841,853 | 2,553,278 | ||
| Total liabilities and shareholders' equity | $29,480,672 | $23,937,116 | ||
| Net interest spread | 2.63% | 2.64% | ||
| Net interest margin | 2.73 | 3.09 |
58
| ASSETS | Nine Months Ended September 30, 2020 Average Balance | Average Yield/Rate | 2019 Average Balance | Average Yield/Rate |
|---|---|---|---|---|
| Loans, net of unearned interest | $14,818,893 | 3.91% | $12,607,157 | 5.10% |
| Securities: | ||||
| Taxable | 5,082,153 | 2.09 | 4,481,242 | 2.36 |
| Tax-exempt | 4,169,829 | 3.02 | 3,730,744 | 2.98 |
| Total securities | 9,251,982 | 2.51 | 8,211,986 | 2.64 |
| Federal funds and resell agreements | 1,070,071 | 1.16 | 414,560 | 2.89 |
| Interest-bearing due from banks | 1,140,965 | 0.39 | 563,810 | 2.40 |
| Other earning assets | 39,580 | 4.55 | 50,841 | 5.05 |
| Total earning assets | 26,321,491 | 3.15 | 21,848,354 | 4.07 |
| Allowance for credit losses | (173,254) | (106,565) | ||
| Other assets | 1,742,652 | 1,607,087 | ||
| Total assets | $27,890,889 | $23,348,876 | ||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
| Interest-bearing deposits | $15,107,688 | 0.44% | $12,897,172 | 1.23% |
| Federal funds and repurchase agreements | 2,043,942 | 0.66 | 1,655,934 | 2.09 |
| Borrowed funds | 90,849 | 6.36 | 69,669 | 7.89 |
| Total interest-bearing liabilities | 17,242,479 | 0.50 | 14,622,775 | 1.36 |
| Noninterest-bearing demand deposits | 7,475,746 | 6,040,019 | ||
| Other liabilities | 411,547 | 283,863 | ||
| Shareholders' equity | 2,761,117 | 2,402,219 | ||
| Total liabilities and shareholders' equity | $27,890,889 | $23,348,876 | ||
| Net interest spread | 2.65% | 2.71% | ||
| Net interest margin | 2.82 | 3.16 |
Table 2 presents the dollar amount of change in net interest income and margin due to volume and rate. Table 2 also reflects the effect that interest-free funds have on net interest margin. The average balance of interest-free funds (total earning assets less interest-bearing liabilities) increased $2.5 billion for the three-month period ended September 30, 2020, and increased $1.9 billion for the nine-month period ended June 30, 2020, compared to the same periods in 2019. The benefit from interest-free funds decreased 35 and 28 basis points in the three and nine-month periods, respectively, due to decreased yields on earning assets, offset by a decrease in interest rates of interest-bearing liabilities.
ANALYSIS OF CHANGES IN NET INTEREST INCOME AND MARGIN (unaudited, dollars in thousands)
ANALYSIS OF CHANGES IN NET INTEREST INCOME
| Change in interest earned on: | Three Months Ended September 30, 2020 and 2019 Volume | Rate | Total | Nine Months Ended September 30, 2020 and 2019 Volume | Rate | Total |
|---|---|---|---|---|---|---|
| Loans | $31,074 | $(50,876) | $(19,802) | $76,229 | $(124,100) | $(47,871) |
| Securities: | ||||||
| Taxable | 4,419 | (4,992) | (573) | 9,995 | (9,577) | 418 |
| Tax-exempt | 3,061 | (886) | 2,175 | 7,738 | 768 | 8,506 |
| Federal funds sold and resell agreements | 2,588 | (3,157) | (569) | 8,028 | (7,723) | 305 |
| Interest-bearing due from banks | 1,626 | (4,777) | (3,151) | 5,601 | (12,358) | (6,757) |
| Trading | (99) | (67) | (166) | (328) | (148) | (476) |
| Interest income | 42,669 | (64,755) | (22,086) | 107,263 | (153,138) | (45,875) |
| Change in interest incurred on: | ||||||
| Interest-bearing deposits | 6,857 | (38,717) | (31,860) | 17,605 | (85,840) | (68,235) |
| Federal funds purchased and repurchase agreements | 1,189 | (7,772) | (6,583) | 5,024 | (20,887) | (15,863) |
| Other borrowed funds | 723 | (490) | 233 | 1,105 | (894) | 211 |
| Interest expense | 8,769 | (46,979) | (38,210) | 23,734 | (107,621) | (83,887) |
| Net interest income | $33,900 | $(17,776) | $16,124 | $83,529 | $(45,517) | $38,012 |
ANALYSIS OF NET INTEREST MARGIN
| Three Months Ended September 30, 2020 | 2019 | Change | Nine Months Ended September 30, 2020 | 2019 | Change | |
|---|---|---|---|---|---|---|
| Average earning assets | $27,844,974 | $22,389,878 | $5,455,096 | $26,321,491 | $21,848,354 | $4,473,137 |
| Interest-bearing liabilities | 17,947,121 | 14,979,431 | 2,967,690 | 17,242,479 | 14,622,775 | 2,619,704 |
| Interest-free funds | $9,897,853 | $7,410,447 | $2,487,406 | $9,079,012 | $7,225,579 | $1,853,433 |
| Free funds ratio (interest free funds to average earning assets) | 35.55% | 33.10% | 2.45% | 34.49% | 33.07% | 1.42% |
| Tax-equivalent yield on earning assets | 2.91 | 3.99 | (1.08) | 3.15 | 4.07 | (0.92) |
| Cost of interest-bearing liabilities | 0.28 | 1.35 | (1.07) | 0.50 | 1.36 | (0.86) |
| Net interest spread | 2.63 | 2.64 | (0.01) | 2.65 | 2.71 | (0.06) |
| Benefit of interest-free funds | 0.10 | 0.45 | (0.35) | 0.17 | 0.45 | (0.28) |
| Net interest margin | 2.73% | 3.09% | (0.36)% | 2.82% | 3.16% | (0.34)% |
Provision and Allowance for Credit Losses
The ACL represents management’s judgment of the total expected losses included in the Company’s loan portfolio as of the balance sheet date. The Company’s process for recording the ACL is based on the evaluation of the Company’s lifetime historical loss experience, management’s understanding of the credit quality inherent in the loan portfolio, and the impact of the current economic environment, coupled with reasonable and supportable economic forecasts.
A mathematical calculation of an estimate is made to assist in determining the adequacy and reasonableness of management’s recorded ACL. To develop the estimate, the Company follows the guidelines in ASC Topic 326, Financial Instruments – Credit Losses. The estimate reserves for assets held at amortized cost and any related credit deterioration in the Company’s available-for-sale debt security portfolio. Assets held at amortized cost include the Company’s loan book and held-to-maturity security portfolio.
The process involves the consideration of quantitative and qualitative factors relevant to the specific segmentation of loans. These factors have been established over decades of financial institution experience and include economic observation and loan loss characteristics. This process is designed to produce a lifetime estimate of the losses, at a reporting date, that includes evaluation of historical loss experience, current economic conditions, reasonable and supportable forecasts, and the qualitative framework outlined by the Office of the Comptroller of the Currency in the published 2020 Interagency Policy Statement. This process allows management to take a holistic view of the recorded ACL reserve and ensure that all significant and pertinent information is considered.
The Company considers a variety of factors to ensure the safety and soundness of its estimate including a strong internal control framework, extensive methodology documentation, credit underwriting standards which encompass the Company’s desired risk profile, model validation, and ratio analysis. If the Company’s total ACL estimate, as determined in accordance with the approved ACL methodology, is either outside a reasonable range based on review of economic indicators or by comparison of historical ratio analysis, the ACL estimate is an outlier and management will investigate the underlying reason(s). Based on that investigation, issues or factors that previously had not been considered may be identified in the estimation process, which may warrant adjustments to estimated credit losses.
The ending result of this process is a recorded consolidated ACL that represents management’s best estimate of the total expected losses included in the loan portfolio, held-to-maturity securities, and credit deterioration in available-for-sale securities.
Based on the factors above, management of the Company recorded $16.0 million and $125.5 million as provision for credit losses for the three and nine-month periods ended September 30, 2020, respectively, compared to $7.5 million and $30.9 million for the same periods in 2019, respectively. As illustrated in Table 3 below, the ACL on loans increased to 1.33% of total loans as of September 30, 2020, compared to 0.82% of total loans as of September 30, 2019.
Table 3 presents a summary of the Company’s ACL for the nine-month periods ended September 30, 2020 and 2019, and for the year ended December 31, 2019. Net charge-offs were $18.3 million for the nine-month period ended September 30, 2020, compared to $27.1 million for the same period in 2019. See “Credit Risk Management” under “Item 3. Quantitative and Qualitative Disclosures About Market Risk” in this report for information relating to nonaccrual loans, past due loans, restructured loans and other credit risk matters.
ANALYSIS OF ALLOWANCE FOR CREDIT LOSSES (unaudited, dollars in thousands)
| Nine Months Ended September 30, 2020 | 2019 | Year Ended December 31, 2019 | |
|---|---|---|---|
| Allowance - January 1 | $101,788 | $103,635 | $103,635 |
| Cumulative effect adjustment(1) | 9,030 | — | — |
| Provision for credit losses | 122,000 | 30,850 | 32,850 |
| Charge-offs: | |||
| Commercial and industrial | (6,990) | (10,123) | (19,267) |
| Specialty lending | — | (15,919) | (16,813) |
| Commercial real estate | (11,920) | (392) | (392) |
| Consumer real estate | (219) | (50) | (52) |
| Consumer | (513) | (677) | (909) |
| Credit cards | (5,953) | (6,421) | (8,647) |
| Leases and other | (11) | — | — |
| Total charge-offs | (25,606) | (33,582) | (46,080) |
| Recoveries: | |||
| Commercial and industrial | 5,640 | 3,361 | 3,579 |
| Specialty lending | — | 56 | 3,992 |
| Commercial real estate | 82 | 713 | 738 |
| Consumer real estate | 57 | 241 | 384 |
| Consumer | 271 | 369 | 509 |
| Credit cards | 1,232 | 1,763 | 2,181 |
| Leases and other | — | — | — |
| Total recoveries | 7,282 | 6,503 | 11,383 |
| Net charge-offs | (18,324) | (27,079) | (34,697) |
| Allowance for credit losses - end of period | $214,494 | $107,406 | $101,788 |
| Allowance for credit losses on loans | $211,688 | $107,406 | $101,788 |
| Allowance for credit losses on held to maturity securities | 2,806 | N/A(1) | N/A(1) |
| Loans at end of period, net of unearned interest | 15,950,177 | 13,043,840 | 13,431,722 |
| Held to maturity securities at end of period | 1,070,307 | 1,102,005 | 1,116,102 |
| Total assets at amortized cost | 17,020,484 | 14,145,845 | 14,547,824 |
| Average loans, net of unearned interest | 14,803,943 | 12,603,268 | 12,759,387 |
| Allowance for credit losses on loans to loans at end of period | 1.33% | 0.82% | 0.76% |
| Allowance for credit losses - end of period to total assets at amortized cost | 1.26% | N/A(1) | N/A(1) |
| Allowance as a multiple of net charge-offs | 8.76x | 2.97x | 2.93x |
| Net charge-offs to average loans | 0.17% | 0.29% | 0.27% |
(1) Related to the adoption of ASU No. 2016-13. See Note 3, “New Accounting Pronouncements,” for further detail.
Noninterest Income
A key objective of the Company is the growth of noninterest income to provide a diverse source of revenue not directly tied to interest rates. Fee-based services are typically non-credit related and are not generally affected by fluctuations in interest rates.
The Company offers multiple fee-based products and services, which management believes will more closely align with customer demands. The Company is currently emphasizing fee-based products and services including trust and securities processing, bankcard, securities trading and brokerage, and cash and treasury management.
Management believes that it can offer these products and services both efficiently and profitably, as most have common platforms and support structures.
SUMMARY OF NONINTEREST INCOME (unaudited, dollars in thousands)
| Three Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Trust and securities processing | $50,552 | $45,218 | $5,334 | 11.8% |
| Trading and investment banking | 8,678 | 5,712 | 2,966 | 51.9 |
| Service charges on deposits | 19,650 | 20,620 | (970) | (4.7) |
| Insurance fees and commissions | 259 | 320 | (61) | (19.1) |
| Brokerage fees | 4,819 | 8,102 | (3,283) | (40.5) |
| Bankcard fees | 15,295 | 16,895 | (1,600) | (9.5) |
| Gains on sales of securities available for sale, net | 311 | 3,057 | (2,746) | (89.8) |
| Other | 13,432 | 3,711 | 9,721 | >100.0 |
| Total noninterest income | $112,996 | $103,635 | $9,361 | 9.0% |
| Nine Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Trust and securities processing | $143,873 | $130,078 | $13,795 | 10.6% |
| Trading and investment banking | 23,252 | 16,746 | 6,506 | 38.9 |
| Service charges on deposits | 63,805 | 62,648 | 1,157 | 1.8 |
| Insurance fees and commissions | 1,051 | 1,123 | (72) | (6.4) |
| Brokerage fees | 20,432 | 22,422 | (1,990) | (8.9) |
| Bankcard fees | 44,756 | 50,401 | (5,645) | (11.2) |
| Gains on sales of securities available for sale, net | 5,544 | 2,463 | 3,081 | >100.0 |
| Other | 29,163 | 30,534 | (1,371) | (4.5) |
| Total noninterest income | $331,876 | $316,415 | $15,461 | 4.9% |
Noninterest income increased by $9.4 million, or 9.0%, during the three-month period ended September 30, 2020, and increased $15.5 million, or 4.9%, during the nine-month period ended September 30, 2020, compared to the same periods in 2019. Table 4 above summarizes the components of noninterest income and the respective year-over-year comparison for each category.
Trust and securities processing income consists of fees earned on personal and corporate trust accounts, custody of securities services, trust investments and wealth management services, mutual fund assets, and alternative asset servicing. The increase in these fees for the three and nine-month periods ended September 30, 2020, compared to the same periods in 2019, was primarily due to an increase in corporate trust and fund services revenues. For the three-month period ended June 30, 2020, fund services revenue increased $3.7 million, or 17.6% and corporate trust revenue increased $1.6 million, or 21.3%. For the nine-month period ended September 30, 2020, fund services revenue increased $8.2 million, or 13.4%, and corporate trust revenue increased $5.8 million, or 28.3%. The recent volatile markets have impacted the income in this category. Since trust and securities processing fees are primarily asset-based, which are highly correlated to the change in market value of the assets, the related income for the remainder of the year will be affected by changes in the securities markets. Management continues to emphasize sales of services to both new and existing clients as well as increasing and improving the distribution channels.
Trading and investment banking fees for the three and nine-month periods ended September 30, 2020 increased $3.0 million, or 51.9%, and $6.5 million, or 38.9%, respectively, compared to the same periods in 2019. These increases were primarily driven by increased trading volume and increased market valuations of investments in the Company’s trading portfolio. The income in this category is market driven and impacted by general increases or decreases in trading volume.
Service charges on deposit accounts for the three-month period ended September 30, 2020 decreased by $1.0 million, or 4.7%, compared to the same period last year, driven by lower corporate service charges and return item fees. For the nine-month period, service charges on deposit accounts increased $1.2 million, or 1.8%, compared to the same period last year, primarily driven by income related to healthcare customer transfer and conversion fees recorded in the first quarter of 2020, offset by lower corporate service charges and return item fees.
Brokerage fees for the three and nine-month periods ended September 30, 2020, decreased $3.3 million, or 40.5%, and $2.0 million, or 8.9%, respectively as compared to the same periods in 2019. These decreases were driven by lower 12b-1 fees. The recent reduction in short-term interest rates will impact the income in this category the remainder of the year.
During the three and nine-month periods ended September 30, 2020, $0.3 million and $5.5 million in gains, respectively, were recognized on the sales of securities available for sale, compared to gains on the sales of securities available for sale of $3.1 million and $2.5 million for the same periods in 2019. The investment portfolio is continually evaluated for opportunities to improve its performance and risk profile relative to market conditions and the Company’s interest rate expectations. This can result in differences from quarter to quarter in the amount of realized gains or losses.
Other noninterest income for the three-month period ended September 30, 2020, increased $9.7 million, or 262.0%, driven by increased company-owned life insurance and increased derivative income. For the nine-month period, other noninterest income decreased $1.4 million, or 4.5%, compared to the same period in 2019. This decrease was primarily driven by decreases in company-owned life insurance, offset by an increase in equity earnings on alternative investments and derivative income.
SUMMARY OF NONINTEREST EXPENSE (unaudited, dollars in thousands)
| Three Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Salaries and employee benefits | $124,194 | $110,153 | $14,041 | 12.7% |
| Occupancy, net | 12,027 | 12,240 | (213) | (1.7) |
| Equipment | 20,968 | 19,775 | 1,193 | 6.0 |
| Supplies and services | 3,442 | 4,261 | (819) | (19.2) |
| Marketing and business development | 3,038 | 5,655 | (2,617) | (46.3) |
| Processing fees | 12,812 | 13,619 | (807) | (5.9) |
| Legal and consulting | 7,244 | 8,374 | (1,130) | (13.5) |
| Bankcard | 4,834 | 4,643 | 191 | 4.1 |
| Amortization of other intangible assets | 1,524 | 1,335 | 189 | 14.2 |
| Regulatory fees | 2,309 | 2,749 | (440) | (16.0) |
| Other | 5,603 | 8,593 | (2,990) | (34.8) |
| Total noninterest expense | $197,995 | $191,397 | $6,598 | 3.4% |
64
| Nine Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Salaries and employee benefits | $366,192 | $340,639 | $25,553 | 7.5% |
| Occupancy, net | 35,618 | 35,522 | 96 | 0.3 |
| Equipment | 63,711 | 58,283 | 5,428 | 9.3 |
| Supplies and services | 11,412 | 12,419 | (1,007) | (8.1) |
| Marketing and business development | 10,962 | 17,872 | (6,910) | (38.7) |
| Processing fees | 39,805 | 38,847 | 958 | 2.5 |
| Legal and consulting | 19,574 | 21,503 | (1,929) | (9.0) |
| Bankcard | 14,243 | 13,689 | 554 | 4.0 |
| Amortization of other intangible assets | 4,916 | 3,913 | 1,003 | 25.6 |
| Regulatory fees | 7,886 | 8,549 | (663) | (7.8) |
| Other | 20,828 | 24,174 | (3,346) | (13.8) |
| Total noninterest expense | $595,147 | $575,410 | $19,737 | 3.4% |
Noninterest expense increased by $6.6 million, or 3.4%, and $19.7 million, or 3.4%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019. Included in these variances were $1.4 million and $5.6 million, respectively, of non-recurring COVID-19 expenses in 2020 and increases of $2.7 million and $3.7 million, respectively, in severance expenses for the three and nine-month periods ended September 30, 2020, as compared to the same periods in 2019. Table 5 above summarizes the components of noninterest expense and the respective year-over-year comparison for each category.
Salaries and employee benefits increased by $14.0 million, or 12.7%, and $25.6 million, or 7.5%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019. Salaries and wages increased $2.5 million, or 3.5%, and increased $11.8 million, or 5.6%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019. Employee benefits expense increased $4.2 million, or 24.9%, and decreased $1.5 million, or 2.3%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019 driven by changes in deferred compensation expense. Bonus and commission expense increased $7.3 million, or 35.0%, and $15.2 million, or 23.1%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019.
Equipment expense increased $1.2 million, or 6.0%, and $5.4 million, or 9.3%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019, primarily due to higher software, equipment maintenance, and COVID-19 specific costs.
Marketing and business development expense decreased $2.6 million, or 46.3%, and $6.9 million, or 38.7%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019, primarily due to lower travel and entertainment expense.
Legal and consulting expense decreased $1.1 million, or 13.5%, and $1.9 million, or 9.0%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019, primarily due to the timing of multiple projects.
Other expense decreased $3.0 million, or 34.8%, and $3.3 million, or 13.8%, for the three and nine-month periods ended September 30, 2020, respectively, compared to the same periods in 2019, primarily due changes in derivative valuations.
Income Tax Expense
The Company’s effective tax rate was 11.9% for the nine months ended September 30, 2020, compared to 15.1% for the same period in 2019. The decrease in the effective tax rate for 2020 is primarily attributable to a larger portion of pre-tax income being earned from tax-exempt municipal securities.
Strategic Lines of Business
The Company has strategically aligned its operations into the following three reportable Business Segments: Commercial Banking, Institutional Banking, and Personal Banking. The Company’s senior executive officers regularly evaluate Business Segment financial results produced by the Company’s internal reporting system in deciding how to allocate resources and assess performance for individual Business Segments. Prior to 2020, the Company had the following four Business Segments: Commercial Banking, Institutional Banking, Personal Banking, and Healthcare Services. In the first quarter of 2020, the Company merged the Healthcare Services segment into the Institutional Banking segment to better reflect how the Company’s core businesses, products and services are currently being evaluated by management. For comparability purposes, amounts in all periods are based on methodologies in effect at September 30, 2020. Previously reported results have been reclassified in this Form 10-Q to conform to the Company’s current organizational structure.
Commercial Banking Operating Results (unaudited, dollars in thousands)
| Three Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $122,362 | $104,360 | $18,002 | 17.2% |
| Provision for credit losses | 14,032 | 5,966 | 8,066 | >100.0 |
| Noninterest income | 22,464 | 18,874 | 3,590 | 19.0 |
| Noninterest expense | 65,175 | 66,447 | (1,272) | (1.9) |
| Income before taxes | 65,619 | 50,821 | 14,798 | 29.1 |
| Income tax expense | 8,100 | 7,390 | 710 | 9.6 |
| Net income | $57,519 | $43,431 | $14,088 | 32.4% |
| Nine Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $342,406 | $306,752 | $35,654 | 11.6% |
| Provision for credit losses | 115,533 | 25,602 | 89,931 | >100.0 |
| Noninterest income | 57,782 | 62,442 | (4,660) | (7.5) |
| Noninterest expense | 186,341 | 201,777 | (15,436) | (7.7) |
| Income before taxes | 98,314 | 141,815 | (43,501) | (30.7) |
| Income tax expense | 11,709 | 21,482 | (9,773) | (45.5) |
| Net income | $86,605 | $120,333 | $(33,728) | (28.0)% |
For the nine-month period ended September 30, 2020, Commercial Banking net income decreased by $33.7 million, or 28.0%, to $86.6 million, as compared to the same period in 2019. Net interest income increased $35.7 million, or 11.6%, for the nine-month period ended September 30, 2020, compared to the same period in 2019, primarily driven by strong loan growth and earning asset mix changes. Commercial Banking added loans of $1.5 billion and loan interest income of $15.6 million related to the PPP during the second and third quarters of 2020. Provision for credit losses increased by $89.9 million for the period due to adoption of CECL, coupled with the current economic environment and reasonable and supportable economic forecasts. The impacts of the COVID-19 pandemic are key elements of these forecasts. Noninterest income decreased $4.7 million, or 7.5%, over the same period in 2019 primarily due to a decrease of $2.2 million in bankcard fees driven by decreased interchange income, a decrease of $2.1 million in other noninterest income due to decreased company-owned life insurance income, and a decrease of $1.2 million in deposit service charges. Noninterest expense decreased $15.4 million, or 7.7%, to $186.3 million for the nine-month period ended September 30, 2020, compared to the same period in 2019. This decrease was driven by an $11.2 million decrease in technology, service, and overhead expenses, a decrease of $2.8 million in marketing and business development expense due to decreased travel and entertainment expense as a result of the COVID-19 pandemic, and a decrease of $1.1 million in processing fees.
Institutional Banking Operating Results (unaudited, dollars in thousands)
| Three Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $23,375 | $30,604 | $(7,229) | (23.6)% |
| Provision for credit losses | 193 | 256 | (63) | (24.6) |
| Noninterest income | 62,688 | 58,643 | 4,045 | 6.9 |
| Noninterest expense | 69,667 | 66,622 | 3,045 | 4.6 |
| Income before taxes | 16,203 | 22,369 | (6,166) | (27.6) |
| Income tax expense | 2,000 | 3,254 | (1,254) | (38.5) |
| Net income | $14,203 | $19,115 | $(4,912) | (25.7)% |
| Nine Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $84,534 | $92,857 | $(8,323) | (9.0)% |
| Provision for credit losses | 766 | 723 | 43 | 5.9 |
| Noninterest income | 191,128 | 170,118 | 21,010 | 12.4 |
| Noninterest expense | 215,073 | 196,871 | 18,202 | 9.2 |
| Income before taxes | 59,823 | 65,381 | (5,558) | (8.5) |
| Income tax expense | 7,125 | 9,903 | (2,778) | (28.1) |
| Net income | $52,698 | $55,478 | $(2,780) | (5.0)% |
For the nine-month period ended September 30, 2020, Institutional Banking net income decreased $2.8 million, or 5.0%, compared to the same period last year. Net interest income decreased $8.3 million, or 9.0%, compared to the same period last year, driven by a decrease in funds transfer pricing due to the decline in interest rates. Noninterest income increased $21.0 million, or 12.4%, primarily due to increases of $10.3 million in bond trading income, $6.4 million in fund services income and $5.8 million in corporate trust income, both recorded in trust and securities processing revenue, and $4.4 million in service charges on deposit accounts due to healthcare customer transfer and conversion fees. These increases were partially offset by a decrease of $3.4 million in bankcard fees driven by lower interchange income and a decrease of $2.3 million in brokerage fees primarily due to lower 12b-1 fee income. Noninterest expense increased $18.2 million, or 9.2%, primarily driven by an increase of $10.3 million in salary and employee benefits expense, an increase of $6.4 million in technology, service, and overhead expenses, increased bankcard expense of $1.8 million, and increased amortization expense of $1.6 million. These increases were partially offset by a decrease of $1.7 million in marketing and business development expense due to decreased travel and entertainment expense as a result of the COVID-19 pandemic.
Personal Banking Operating Results (unaudited, dollars in thousands)
| Three Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $38,647 | $33,296 | $5,351 | 16.1% |
| Provision for credit losses | 1,775 | 1,278 | 497 | 38.9 |
| Noninterest income | 27,844 | 26,118 | 1,726 | 6.6 |
| Noninterest expense | 63,153 | 58,328 | 4,825 | 8.3 |
| Income (loss) before taxes | 1,563 | (192) | 1,755 | >100.0 |
| Income tax expense (benefit) | 193 | (28) | 221 | >100.0 |
| Net income (loss) | $1,370 | $(164) | $1,534 | >100.0% |
| Nine Months Ended September 30, 2020 | 2019 | Dollar Change 20-19 | Percent Change 20-19 | |
|---|---|---|---|---|
| Net interest income | $109,614 | $98,933 | $10,681 | 10.8% |
| Provision for credit losses | 9,201 | 4,525 | 4,676 | >100.0 |
| Noninterest income | 82,966 | 83,855 | (889) | (1.1) |
| Noninterest expense | 193,733 | 176,762 | 16,971 | 9.6 |
| (Loss) income before taxes | (10,354) | 1,501 | (11,855) | (>100.0) |
| Income tax (benefit) expense | (1,233) | 227 | (1,460) | (>100.0) |
| Net (loss) income | $(9,121) | $1,274 | $(10,395) | (>100.0)% |
For the nine-month period ended September 30, 2020, Personal Banking recognized a net loss of $9.1 million, which represents a decrease of $10.4 million as compared to the same period last year. Net interest income increased $10.7 million, or 10.8%, compared to the same period last year due to increased loan balances. Provision for credit losses increased $4.7 million due to adoption of CECL, coupled with the current economic environment and reasonable and supportable economic forecasts. The impacts of the COVID-19 pandemic are key elements of these forecasts. Noninterest income decreased $0.9 million, or 1.1%, for the same period. This decrease is primarily driven by a decrease of $2.0 million in deposit service charges and a decrease of $1.1 million in other noninterest income due to lower company-owned life insurance income. These decreases were partially offset by an increase of $2.0 million in equity earnings on alternative investments. Noninterest expense increased $17.0 million, or 9.6%, primarily due to an increase of $10.1 million in technology, service, and overhead expenses, $6.6 million in salary and employee benefits expense, and $1.8 million in other expense due to higher operational losses recorded in 2020. These increases were partially offset by a decrease of $0.7 million in marketing and business development expense due to decreased travel and entertainment expense as a result of the COVID-19 pandemic, and a decrease of $0.7 million in furniture and equipment expense.
Balance Sheet Analysis
Total assets of the Company increased by $3.7 billion, or 13.9%, as of September 30, 2020, compared to December 31, 2019, primarily due to an increase of $2.5 billion, or 18.8%, in loan balances and an increase of $1.3 billion, or 17.1%, in available for sale securities.
Total assets of the Company increased $6.1 billion, or 25.3%, as of September 30, 2020, compared to September 30, 2019, primarily due to an increase in loan balances of $2.9 billion, or 22.3%, an increase in AFS securities of $1.3 billion, or 17.6%, an increase in interest-bearing due from banks of $1.5 billion, or 919.1%, and an increase in securities purchased under agreements to resell of $638.2 million, or 137.8%. Total assets, including interest-bearing due from banks and securities purchased under agreements to resell, are being impacted by excess liquidity in the market due to PPP.
SELECTED FINANCIAL INFORMATION (unaudited, dollars in thousands)
| September 30, 2020 | 2019 | December 31, 2019 | |
|---|---|---|---|
| Total assets | $30,250,972 | $24,143,092 | $26,561,355 |
| Loans, net of unearned interest | 15,961,155 | 13,054,865 | 13,439,525 |
| Total securities | 9,998,701 | 8,688,163 | 8,717,502 |
| Interest-bearing due from banks | 1,613,675 | 158,339 | 1,225,491 |
| Total earning assets | 28,460,350 | 22,257,353 | 24,859,075 |
| Total deposits | 24,737,907 | 19,309,345 | 21,603,244 |
| Total borrowed funds | 2,213,048 | 1,861,091 | 1,966,880 |
Loans represent the Company’s largest source of interest income. In addition to growing the commercial loan portfolio, management believes its middle market commercial business and its consumer business, including home equity and credit card loan products, are the market niches that represent its best opportunity to cross-sell fee-related services and generate additional noninterest income for the Company.
Actual loan balances totaled $16.0 billion as of September 30, 2020, and increased $2.5 billion, or 18.8%, compared to December 31, 2019, and increased $2.9 billion, or 22.3%, compared to September 30, 2019. Compared to December 31, 2019, commercial and industrial loans increased $1.4 billion, or 24.7%, commercial real estate loans increased $695.5 million, or 13.5%, and consumer real estate loans increased $447.6 million, or 32.1%. Compared to September 30, 2019, commercial and industrial loans increased $1.7 billion, or 31.1%, commercial real estate loans increased $789.7 million, or 15.6%, and consumer real estate loans increased $532.6 million, or 40.7%, partially offset by a decrease of $109.8 million, or 18.1% in specialty lending loans. The increase in commercial and industrial loans as compared to both December 31, 2019 and September 30, 2019 is primarily related to the Company’s participation in the PPP, with PPP loans totaling $1.5 billion as of September 30, 2020.
Nonaccrual, past due and restructured loans are discussed under “Credit Risk Management” within “Item 3. Quantitative and Qualitative Disclosures About Market Risk” in this report.
Investment Securities
The Company’s investment portfolio contains trading, AFS, and HTM securities, as well as FRB stock, FHLB stock, and other miscellaneous investments. Investment securities totaled $10.0 billion as of September 30, 2020, and $8.7 billion as of December 31, 2019, and comprised 35.1% of the Company’s earning assets as of both dates.
The Company’s AFS securities portfolio comprised 87.2% of the Company’s investment securities portfolio at September 30, 2020 and 85.4% at December 31, 2019. The Company’s AFS securities portfolio provides liquidity as a result of the composition and average life of the underlying securities. This liquidity can be used to fund loan growth or to offset the outflow of traditional funding sources. The average life of the AFS securities portfolio was 70.2 months at September 30, 2020, compared to 70.9 months at December 31, 2019, and 60.8 months at September 30, 2019. In addition to providing a potential source of liquidity, the AFS securities portfolio can be used as a tool to manage interest rate sensitivity. The Company’s goal in the management of its AFS securities portfolio is to maximize return within the Company’s parameters of liquidity goals, interest rate risk, and credit risk.
Management expects collateral pledging requirements for public funds, loan demand, and deposit funding to be the primary factors impacting changes in the level of AFS securities. There were $6.9 billion of AFS securities pledged to secure U.S. Government deposits, other public deposits, certain trust deposits, derivative transactions, and repurchase agreements at September 30, 2020. Of this amount, securities with a market value of $393.6 million at September 30, 2020 were pledged at the Federal Reserve Discount Window but were unencumbered as of that date.
The Company’s HTM securities portfolio consists of private placement bonds, which are issued primarily to refinance existing revenue bonds in the healthcare and education sectors. The HTM portfolio, net of the ACL totaled $1.1 billion at both September 30, 2020 and December 31, 2019. The average life of the HTM portfolio was 6.0 years at September 30, 2020, 6.3 years at December 31, 2019, and 6.4 years at September 30, 2019.
The securities portfolio generates the Company’s second largest component of interest income. The securities portfolio achieved an average yield on a tax-equivalent basis of 2.52% for the nine-month period ended September 30, 2020, compared to 2.66% for the same period in 2019.
Deposits and Borrowed Funds
Deposits increased $3.1 billion, or 14.5%, from December 31, 2019 to September 30, 2020 and increased $5.4 billion, or 28.1%, from September 30, 2019 to September 30, 2020. Noninterest-bearing deposits increased $1.8 billion, and total interest-bearing deposits increased $1.3 billion from December 31, 2019 to September 30, 2020. Total interest-bearing deposits increased $3.3 billion, and noninterest-bearing deposits increased $2.1 billion from September 30, 2019 to September 30, 2020. The increase in deposits as compared to prior periods is related to the excess liquidity in the market created by the PPP and customer behavior changes related to the COVID-19 pandemic.
Deposits represent the Company’s primary funding source for its asset base. In addition to the core deposits garnered by the Company’s retail branch structure, the Company continues to focus on its cash management services, as well as its trust and mutual fund servicing businesses, in order to attract and retain additional deposits. Management believes a strong core deposit composition is one of the Company’s key strengths given its competitive product mix.
Long-term debt totaled $269.0 million at September 30, 2020, compared to $70.4 million as of December 31, 2019, and $70.1 million as of September 30, 2019. In September 2020, the Company issued $200.0 million in aggregate subordinated notes due in September 2030. The Company received $197.4 million, after deducting underwriting discounts and commissions and offering expenses, and used the proceeds from the offering for general corporate purposes, including, among other uses, contributing Tier 1 capital into the Bank. The subordinated notes were issued with a fixed-to-fixed rate of 3.70% and an effective rate of 3.93%, due to issuance costs, with an interest rate reset date of September 2025. The remainder of the Company’s long-term debt was assumed from the acquisition of Marquette Financial Companies (Marquette) and consists of debt obligations payable to four unconsolidated trusts (Marquette Capital Trust I, Marquette Capital Trust II, Marquette Capital Trust III, and Marquette Capital Trust IV) that previously issued trust preferred securities. These long-term debt obligations have an aggregate contractual balance of $103.1 million. Interest rates on trust preferred securities are tied to the three-month LIBOR rate with spreads ranging from 133 basis points to 160 basis points, and reset quarterly. The trust preferred securities have maturity dates ranging from January 2036 to September 2036.
The Company has a revolving line of credit with Wells Fargo Bank, N.A. which allows the Company to borrow up to $50.0 million for general working capital purposes. The interest rate applied to borrowed balances will be at the Company’s option either 1.00% above LIBOR or 1.75% below the prime rate on the date of an advance. The Company pays a 0.3% unused commitment fee for unused portions of the revolving line of credit. As of September 30, 2020, the Company had an outstanding balance of $15.0 million on this revolving line of credit. This borrowing is included in the Short-term debt line on the Company’s Consolidated Balance Sheets.
Federal funds purchased and securities sold under agreements to repurchase totaled $1.9 billion as of September 30, 2020 and December 31, 2019, and $1.8 billion at September 30, 2019. Repurchase agreements are transactions involving the exchange of investment funds by the customer for securities by the Company under an agreement to repurchase the same or similar issues at an agreed-upon price and date. The level of borrowings could be impacted by earning asset mix changes in the Company’s balance sheet from the impacts of the COVID-19 pandemic.
Capital and Liquidity
The Company places a significant emphasis on the maintenance of a strong capital position, which promotes investor confidence, provides access to funding sources under favorable terms, and enhances the Company’s ability to capitalize on business growth and acquisition opportunities. Higher levels of liquidity, however, bear corresponding costs, measured in terms of lower yields on short-term, more liquid earning assets and higher expenses for extended liability maturities. The Company manages capital for each subsidiary based upon the subsidiary’s respective risks and growth opportunities as well as regulatory requirements.
Total shareholders’ equity was $2.9 billion at September 30, 2020, a $247.7 million increase compared to December 31, 2019, and a $290.3 million increase compared to September 30, 2019.
The Company’s Board of Directors authorized, at its April 28, 2020, April 23, 2019, and April 24, 2018 meetings, the repurchase of up to two million shares of the Company’s common stock during the twelve months following each meeting (each a Repurchase Authorization). During the nine-month periods ended September 30, 2020 and 2019, the Company acquired 1,140,399 shares and 65,463 shares, respectively, of its common stock pursuant to the applicable Repurchase Authorization. In March 2020, the Company entered into an agreement with Bank of America (BoA) to repurchase an aggregate of $30.0 million of the Company’s common stock through an accelerated share repurchase agreement (the ASR). The Company repurchased a total of 653,498 shares under the ASR, which was completed during the second quarter. The ASR was entered into pursuant to the April 23, 2019 Repurchase Authorization and the Company has not made any repurchase of its securities other than pursuant to the Repurchase Authorizations. The Company is not currently engaging in repurchases. In the future, it may determine to resume repurchases.
At the Company’s quarterly board meeting, the Board of Directors declared a $0.32 per share quarterly cash dividend payable on January 4, 2021, to shareholders of record at the close of business on December 10, 2020.
Through the Company’s relationship with the FHLB of Des Moines, the Company owns $10.0 million of FHLB stock and has access to additional liquidity and funding sources through FHLB advances. The Company’s borrowing capacity is dependent upon the amount of collateral the Company places at the FHLB. The Company’s borrowing capacity with the FHLB was $1.4 billion as of September 30, 2020. The Company had no outstanding FHLB advances at FHLB of Des Moines as of September 30, 2020.
Risk-based capital guidelines established by regulatory agencies set minimum capital standards based on the level of risk associated with a financial institution’s assets. The Company has implemented the Basel III regulatory capital rules adopted by the FRB. Basel III capital rules include a minimum ratio of common equity tier 1 capital to risk-weighted assets of 4.5% and a minimum tier 1 risk-based capital ratio of 6%. A financial institution’s total capital is also required to equal at least 8% of risk-weighted assets.
The risk-based capital guidelines indicate the specific risk weightings by type of asset. Certain off-balance sheet items (such as standby letters of credit and binding loan commitments) are multiplied by credit conversion factors to translate them into balance sheet equivalents before assigning them specific risk weightings. The Company is also required to maintain a leverage ratio equal to or greater than 4%. The leverage ratio is calculated as the ratio of tier 1 core capital to total average assets, less goodwill and intangibles.
U.S. banking agencies in December 2018 approved a final rule to address the impact of CECL on regulatory capital by allowing banking organizations the option to phase in the day-one impact of CECL until the first quarter of 2023. In March 2020, the U.S. banking agencies issued an interim final rule that provides banking organizations with an alternative option to delay for two years an estimate of CECL’s effect on regulatory capital, relative to the incurred loss methodology’s effect on regulatory capital, followed by a three-year transition period. The Company is electing this alternative option instead of the one described in the December 2018 rule.
The Company's capital position as of September 30, 2020 is summarized in the table below and exceeded regulatory requirements.
Table 10
| RATIOS | Three Months Ended September 30, 2020 | 2019 | Nine Months Ended September 30, 2020 | 2019 |
|---|---|---|---|---|
| Common equity tier 1 capital ratio | 11.93% | 12.53% | 11.93% | 12.53% |
| Tier 1 risk-based capital ratio | 11.93 | 12.53 | 11.93 | 12.53 |
| Total risk-based capital ratio | 14.17 | 13.51 | 14.17 | 13.51 |
| Leverage ratio | 8.19 | 9.62 | 8.19 | 9.62 |
| Return on average assets | 0.99 | 1.03 | 0.62 | 1.01 |
| Return on average equity | 10.23 | 9.69 | 6.30 | 9.86 |
| Average equity to assets | 9.64 | 10.67 | 9.90 | 10.29 |
The Company's per share data is summarized in the table below.
| Per Share Data | Three Months Ended September 30, 2020 | 2019 | Nine Months Ended September 30, 2020 | 2019 |
|---|---|---|---|---|
| Earnings - basic | $1.52 | $1.28 | $2.70 | $3.63 |
| Earnings - diluted | 1.52 | 1.27 | 2.69 | 3.61 |
| Cash dividends | 0.31 | 0.30 | 0.93 | 0.90 |
| Dividend payout ratio | 20.39% | 23.44% | 34.44% | 24.79% |
| Book value | $59.43 | $52.23 | $59.43 | $52.23 |
Off-balance Sheet Arrangements
The Company’s main off-balance sheet arrangements are loan commitments, commercial and standby letters of credit, futures contracts and forward exchange contracts, which have maturity dates rather than payment due dates. See Note 10, “Commitments, Contingencies and Guarantees” in the Notes to Consolidated Financial Statements for detailed information on these arrangements. The level of the outstanding commitments will be impacted by financial impacts related to the COVID-19 pandemic.
Critical Accounting Policies and Estimates
The preparation of these Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates and judgments, including those related to customers and suppliers, allowance for credit losses, bad debts, investments, financing operations, long-lived assets, taxes, other contingencies, and litigation. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which have formed the basis for making such judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Under different assumptions or conditions, actual results may differ from the recorded estimates.
A summary of critical accounting policies is listed in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of the Form 10-K.
Market risk
As filed, 21,082 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Risk Management
Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange prices, commodity prices, or equity prices. Financial instruments that are subject to market risk can be classified either as held for trading or held for purposes other than trading.
The Company is subject to market risk primarily through the effect of changes in interest rates of its assets held for purposes other than trading. The following discussion of interest rate risk, however, combines instruments held for trading and instruments held for purposes other than trading because the instruments held for trading represent such a small portion of the Company’s portfolio that the interest rate risk associated with them is immaterial.
Interest Rate Risk
In the banking industry, a major risk exposure is changing interest rates. To minimize the effect of interest rate changes to net interest income and exposure levels to economic losses, the Company manages its exposure to changes in interest rates through asset and liability management within guidelines established by its Asset Liability Committee (ALCO) and approved by the Board. The ALCO is responsible for approving and ensuring compliance with asset/liability management policies, including interest rate exposure. The Company’s primary method for measuring and analyzing consolidated interest rate risk is the Net Interest Income Simulation Analysis. The Company also uses a Net Portfolio Value model to measure market value risk under various rate change scenarios and a gap analysis to measure maturity and repricing relationships between interest-earning assets and interest-bearing liabilities at specific points in time. On a limited basis, the Company uses hedges such as swaps, rate floors, and futures contracts to manage interest rate risk on certain loans, trading securities, and trust preferred securities. See further information in Note 11 “Derivatives and Hedging Activities” in the Notes to the Consolidated Financial Statements.
Overall, the Company manages interest rate risk by positioning the balance sheet to maximize net interest income while maintaining an acceptable level of interest rate and credit risk, remaining mindful of the relationship among profitability, liquidity, interest rate risk, and credit risk.
Net Interest Income Modeling
The Company’s primary interest rate risk tool, the Net Interest Income Simulation Analysis, measures interest rate risk and the effect of interest rate changes on net interest income and net interest margin. This analysis incorporates all of the Company’s assets and liabilities together with assumptions that reflect the current interest rate environment. Through these simulations, management estimates the impact on net interest income of a 300 basis point upward or a 200 basis point downward gradual change (e.g. ramp) and immediate change (e.g. shock) of market interest rates over a two year period. In ramp scenarios, rates change gradually for a one-year period and remain constant in year two. In shock scenarios, rates change immediately and the change is sustained for the remainder of the two-year scenario horizon. Assumptions are made to project rates for new loans and deposits based on historical analysis, management outlook and repricing strategies. Asset prepayments and other market risks are developed from industry estimates of prepayment speeds and other market changes. The results of these simulations can be significantly influenced by assumptions utilized and management evaluates the sensitivity of the simulation results on a regular basis.
Table 11 shows the net interest income increase or decrease over the next two years as of September 30, 2020 and 2019 based on hypothetical changes in interest rates and a constant sized balance sheet with runoff being replaced.
MARKET RISK (unaudited)
| Change in basis points | Hypothetical change in interest rate – Rate Ramp Year One September 30, 2020 Percentage change | September 30, 2019 Percentage change | Year Two September 30, 2020 Percentage change | September 30, 2019 Percentage change |
|---|---|---|---|---|
| 300 | 0.6% | (0.2)% | 13.5% | 5.0% |
| 200 | 0.3 | (0.1) | 9.4 | 3.4 |
| 100 | 0.1 | 0.2 | 5.0 | 1.3 |
| Static | — | — | — | — |
| (100) | (2.1) | (0.2) | (6.0) | (4.2) |
| (200) | n/a | (0.7) | n/a | (8.6) |
| Change in basis points | Hypothetical change in interest rate – Rate Shock Year One September 30, 2020 Percentage change | September 30, 2019 Percentage change | Year Two September 30, 2020 Percentage change | September 30, 2019 Percentage change |
|---|---|---|---|---|
| 300 | 4.0% | 3.5% | 16.0% | 7.9% |
| 200 | 2.7 | 2.4 | 11.5 | 5.3 |
| 100 | 1.2 | 1.2 | 6.3 | 2.6 |
| Static | — | — | — | — |
| (100) | (3.7) | (2.2) | (6.4) | (6.2) |
| (200) | n/a | (4.5) | n/a | (11.2) |
The Company is positioned slightly asset sensitive to changes in interest rates. Sensitivity of the rising rate ramps is close to neutral for year one, changing to asset sensitive in year two. For decreasing rate ramps, net interest income is predicted to decrease in year one and two. For rate shocks, net interest income is predicted to increase in year one and two in rising rate scenarios and decrease in falling rate scenarios. Increases and decreases in net interest income in rising and falling rate scenarios are due to yields on earning assets increasing and decreasing more due to changes in market rates than the cost of paying liabilities is projected to increase or decrease. A key assumption underlying these projections is how the Company is projected to price deposits in a rising rate environment being consistent with our history.
Trading Account
The Company carries securities in a trading account that is maintained according to Board-approved policy and procedures. The policy limits the amount and type of securities that can be carried in the trading account, requires compliance with any limits under applicable law and regulations, and mandates the use of a value-at-risk methodology to manage price volatility risks within financial parameters. The risk associated with the carrying of trading securities is offset by utilizing financial instruments including exchange-traded financial futures as well as short sales of U.S. Treasury and Corporate securities. The trading securities and related hedging instruments are marked-to-market daily. The trading account had a balance of $49.2 million as of September 30, 2020, $45.6 million as of December 31, 2019, and $86.1 million as of September 30, 2019. Securities sold not yet purchased (i.e. short positions) totaled $2.5 million at September 30, 2020, $14.6 million as of December 31, 2019, and $26.0 million at September 30, 2019 and are classified within the Other liabilities line of the Company’s Consolidated Balance Sheets.
The Company is subject to market risk primarily through the effect of changes in interest rates of its assets held for purposes other than trading. The discussion in Table 11 above of interest rate risk, however, combines instruments held for trading and instruments held for purposes other than trading, because the instruments held for trading represent such a small portion of the Company’s portfolio that the interest rate risk associated with them is immaterial.
Other Market Risk
The Company has minimal foreign currency risk as a result of foreign exchange contracts. See Note 10 “Commitments, Contingencies and Guarantees” in the notes to the Consolidated Financial Statements.
Credit Risk Management
Credit risk represents the risk that a customer or counterparty may not perform in accordance with contractual terms. The Company utilizes a centralized credit administration function, which provides information on the Bank’s risk levels, delinquencies, an internal ranking system and overall credit exposure. Loan requests are centrally reviewed to ensure the consistent application of the loan policy and standards. In addition, the Company has an internal loan review staff that operates independently of the Bank. This review team performs periodic examinations of the Bank’s loans for credit quality, documentation and loan administration. The respective regulatory authorities governing the Bank also review loan portfolios.
A primary indicator of credit quality and risk management is the level of nonperforming loans. Nonperforming loans include both nonaccrual loans and restructured loans on nonaccrual. The Company’s nonperforming loans increased $21.9 million to $93.7 million at September 30, 2020, compared to September 30, 2019, and increased $37.3 million, compared to December 31, 2019.
The Company had $5.7 million, $2.9 million, and $2.9 million of other real estate owned as of September 30, 2020 and 2019, and December 31, 2019, respectively. Loans past due more than 90 days and still accruing interest totaled $1.4 million as of September 30, 2020, compared to $2.5 million at September 30, 2019 and $2.1 million as of December 31, 2019.
A loan is generally placed on nonaccrual status when payments are past due 90 days or more and/or when management has considerable doubt about the borrower’s ability to repay on the terms originally contracted. The accrual of interest is discontinued and recorded thereafter only when received in cash.
Certain loans are restructured to provide a reduction or deferral of interest or principal due to deterioration in the financial condition of the respective borrowers. The Company had $11.7 million of restructured loans at September 30, 2020, $29.3 million at September 30, 2019, and $19.8 million at December 31, 2019. Those loans modified as part of the Company’s response to the COVID-19 pandemic are not considered to be restructured loans and are discussed further below in Table 13.
LOAN QUALITY (unaudited, dollars in thousands)
| September 30, 2020 | 2019 | December 31, 2019 | |
|---|---|---|---|
| Nonaccrual loans | $82,837 | $57,542 | $36,909 |
| Restructured loans on nonaccrual | 10,858 | 14,296 | 19,438 |
| Total nonperforming loans | 93,695 | 71,838 | 56,347 |
| Other real estate owned | 5,678 | 2,939 | 2,935 |
| Total nonperforming assets | $99,373 | $74,777 | $59,282 |
| Loans past due 90 days or more | $1,372 | $2,466 | $2,069 |
| Restructured loans accruing | 800 | 14,984 | 392 |
| Allowance for credit losses on loans | 211,688 | 107,406 | 101,788 |
| Ratios: | |||
| Nonperforming loans as a percent of loans | 0.59% | 0.55% | 0.42% |
| Nonperforming assets as a percent of loans plus other real estate owned | 0.62 | 0.57 | 0.44 |
| Nonperforming assets as a percent of total assets | 0.33 | 0.31 | 0.22 |
| Loans past due 90 days or more as a percent of loans | 0.01 | 0.02 | 0.02 |
| Allowance for credit losses on loans as a percent of loans | 1.33 | 0.82 | 0.76 |
| Allowance for credit losses on loans as a multiple of nonperforming loans | 2.26x | 1.50x | 1.81x |
COVID-19 Loan Modifications
In response to the COVID-19 pandemic, the Company has taken two primary approaches in assisting our customers by modifying terms of existing loans and loans under the PPP. The Company has taken a proactive approach to assisting its borrowers through individual evaluation and broad-based programs. Modifications granted to borrowers have been payment deferrals taking the form of either full payment deferral or interest-only payments. Based on the circumstances of the borrower, payments have been deferred either 90 days, with the option to extend, or 180 days. Consistent with the Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus, modifications granted to borrowers that are related to COVID-19 are not required to be evaluated as TDRs under ASC 310-40. These modified loans are classified as performing and are not considered past due. Loans are to be placed on non-accrual when it becomes apparent that payment of interest or recovery of all principal is questionable, and the COVID-19 related modification is no longer considered short-term or the modification is deemed ineffective. The Company anticipates additional loans to be modified due to the effects of COVID-19 in the coming periods. Any loans modified are segmented separately with specific prepayment and maturity assumptions within the Company’s ACL. As of September 30, 2020, the Company had 980 COVID-19 related modifications remaining on loans with a total balance of $707.1 million. Within the Company’s non-credit card loan portfolios, over 1,300 loan modifications were made since the COVID-19 pandemic began. Of these loan modifications, approximately 54% of loans have resumed making principal or interest payments as of September 30, 2020. Approximately 12% of loans within the Company’s non-credit card portfolios have had a second modification and are still a current modified loan. Modified credit card balances declined 85% as of September 30, 2020 as compared to June 30, 2020. There have been no charge-offs on modified loans. See further discussion of the impacts of COVID-19 on the Company’s consolidated financial statements in “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
COVID-19 LOAN MODIFICATIONS (unaudited, in thousands)
| As of September 30, 2020 Balance | Modification Type Deferment | Interest Only | |
|---|---|---|---|
| Commercial and industrial | $197,325 | $197,050 | $275 |
| Specialty lending | 3,229 | — | 3,229 |
| Commercial real estate | 476,631 | 440,624 | 36,007 |
| Consumer real estate | 20,410 | 20,410 | — |
| Consumer | 32 | 32 | — |
| Credit cards | 427 | 427 | — |
| Leases and other | — | — | — |
| Held to maturity securities | 9,000 | 9,000 | — |
| Total | $707,054 | $667,543 | $39,511 |
Liquidity Risk
Liquidity represents the Company’s ability to meet financial commitments through the maturity and sale of existing assets or availability of additional funds. The Company believes that the most important factor in the preservation of liquidity is maintaining public confidence that facilitates the retention and growth of a large, stable supply of core deposits and wholesale funds. Ultimately, the Company believes public confidence is generated through profitable operations, sound credit quality and a strong capital position. The primary source of liquidity for the Company is regularly scheduled payments on and maturity of assets, which include $8.7 billion of high-quality securities available for sale as of September 30, 2020. The liquidity of the Company and the Bank is also enhanced by its activity in the federal funds market and by its core deposits. Additionally, management believes it can raise debt or equity capital on favorable terms in the future, should the need arise.
Another factor affecting liquidity is the amount of deposits and customer repurchase agreements that have pledging requirements. All customer repurchase agreements require collateral in the form of a security. The U.S. Government, other public entities, and certain trust depositors require the Company to pledge securities if their deposit balances are greater than the FDIC-insured deposit limitations. These pledging requirements affect liquidity risk in that the related security cannot otherwise be disposed of due to the pledging restriction. At September 30, 2020, $6.9 billion, or 79.3%, of the securities available-for-sale were pledged or used as collateral, compared to $5.8 billion, or 77.5%, at December 31, 2019. However, of these amounts, securities with a market value of $393.6 million at September 30, 2020 and $481.2 million at December 31, 2019 were pledged at the Federal Reserve Discount Window but were unencumbered as of those dates.
The Company also has other commercial commitments that may impact liquidity. These commitments include unused commitments to extend credit, standby letters of credit and financial guarantees, and commercial letters of credit. The total amount of these commercial commitments at September 30, 2020 was $12.2 billion. Since many of these commitments expire without being drawn upon, the total amount of these commercial commitments does not necessarily represent the future cash requirements of the Company.
The Company’s cash requirements consist primarily of dividends to shareholders, debt service, operating expenses, and treasury stock purchases. Management fees and dividends received from bank and non-bank subsidiaries traditionally have been sufficient to satisfy these requirements and are expected to be sufficient in the future. The Bank is subject to various rules regarding payment of dividends to the Company. For the most part, the Bank can pay dividends at least equal to its current year’s earnings without seeking prior regulatory approval. The Company also uses cash to inject capital into its bank and non-bank subsidiaries to maintain adequate capital as well as fund strategic initiatives.
In September 2020, the Company issued $200.0 million in aggregate subordinated notes due in September 2030. The Company received $197.4 million, after deducting underwriting discounts and commissions and offering expenses, and used the proceeds from the offering for general corporate purposes, including, among other uses, contributing Tier 1 capital into the Bank. The subordinated notes were issued with a fixed-to-fixed rate of 3.70% and an effective rate of 3.93%, due to issuance costs, with an interest rate reset date of September 2025.
To enhance general working capital needs, the Company has a revolving line of credit with Wells Fargo Bank, N.A., which allows the Company to borrow up to $50.0 million for general working capital purposes. The interest rate applied to borrowed balances will be at the Company’s option, either 1.00% above LIBOR or 1.75% below the prime rate on the date of an advance. The Company pays a 0.3% unused commitment fee for unused portions of the line of credit. As of September 30, 2020, the Company had an outstanding balance of $15.0 million on this line of credit.
The Company is a member bank of the FHLB. The Company owns $10.0 million of FHLB stock and has access to additional liquidity and funding sources through FHLB advances. Additionally, the Company has access to borrow up to $1.4 billion through advances at the FHLB of Des Moines, but had no outstanding FHLB Des Moines advances as of September 30, 2020.
Operational Risk
Operational risk generally refers to the risk of loss resulting from the Company’s operations, including those operations performed for the Company by third parties. This would include but is not limited to the risk of fraud by employees or persons outside the Company, the execution of unauthorized transactions by employees or others, errors relating to transaction processing, breaches of the internal control system and compliance requirements, and unplanned interruptions in service. This risk of loss also includes the potential legal or regulatory actions that could arise as a result of an operational deficiency, or as a result of noncompliance with applicable regulatory standards. The Company must comply with a number of legal and regulatory requirements.
The Company operates in many markets and relies on the ability of its employees and systems to properly process a high number of transactions. In the event of a breakdown in internal control systems, improper operation of systems or improper employee actions, the Company could suffer financial loss, face regulatory action and suffer damage to its reputation. In order to address this risk, management maintains a system of internal controls with the objective of providing proper transaction authorization and execution, safeguarding of assets from misuse or theft, and ensuring the reliability of financial and other data.
The Company maintains systems of internal controls that provide management with timely and accurate information about the Company’s operations. These systems have been designed to manage operational risk at appropriate levels given the Company’s financial strength, the environment in which it operates, and considering factors such as competition and regulation. The Company has also established procedures that are designed to ensure that policies relating to conduct, ethics, and business practices are followed on a uniform basis. In certain cases, the Company has experienced losses from operational risk. Such losses have included the effects of operational errors that the Company has discovered and included as expense in the statement of income. While there can be no assurance that the Company will not suffer such losses in the future, management continually monitors and works to improve its internal controls, systems, and corporate-wide processes and procedures.
Controls and procedures
As filed, 1,869 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Sarbanes-Oxley Act of 2002, as amended, requires the Chief Executive Officer and the Chief Financial Officer to make certain certifications under this Form 10-Q with respect to the Company’s disclosure controls and procedures and internal control over financial reporting. The Company has a Code of Ethics that expresses the values that drive employee behavior and maintains the Company’s commitment to the highest standards of ethics.
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company's “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this Form 10-Q. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Form 10-Q, the Company’s disclosure controls and procedures were effective for ensuring that the Company’s SEC filings are recorded, processed, summarized, and reported within the time period required and that information required to be disclosed by the Company is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.
Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the nine-month period ended September 30, 2020 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 317 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes to the risk factors as previously disclosed in response to Item 1A to Part I of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, or in response to Item 1A to Part II of the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $12.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $64.6m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $10.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | $17.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | $73.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | $130.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-01 to 2020-09-30 | $1.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-30 | $2.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-01 to 2020-09-30 | $1.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-30 | $2.70 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-01 to 2020-09-30 | 48,068,438 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-30 | 48,352,145 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $215.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $46.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-01-01 to 2020-09-30 | $44.9m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2020-01-01 to 2020-09-30 | $59.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-09-30 | $2.02bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2020-09-30 | $30.25bn | us-gaap:Assets |
| Total liabilities | At period end2020-09-30 | $27.40bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-09-30 | $269.0m | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2020-09-30 | $15.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-09-30 | $2.85bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-048551. Last ingested by Listed: Nov 4, 2026, 17:33 ET. Listed shows no prices and gives no investment advice.